News AZ's Alexion inks wide-ranging AI agreement with Verge AstraZeneca has made a sizeable play in applying artificial intelligence to drug discovery in its rare disease unit Alexion, partnering with Verge Genomics in a deal that
News Verge Genomics takes AI-sourced drug for ALS into clinic Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing.
News 'Trust gap' is holding back AI in healthcare The potential for AI to help tackle bottlenecks in healthcare is being held back by patient scepticism and doctor concerns about bias and liability.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.